In addition, the combination of VEGF-blocking and TGF-β-blocking drugs was reported to exert synergistic inhibitory effects on tumor growth in B16 mice model, and these drugs significantly enhanced anti-PD-1/anti-CTLA-4 therapy and prolonged survival [56]. The gene discussed is VEGFA; the disease is neoplasm.